Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Tight Junction Protein

The Tight Junction Protein (TJP) is located at the topmost side of epithelial and endothelial cells. It is composed of transmembrane proteins such as claudin, occludin, JAMs, and cytoplasmic scaffold proteins like ZO-1/2/3. By connecting the actin cytoskeleton, it forms a selective barrier, separating the internal and external environments and maintaining cell polarity. Targeting TJP can repair barrier damage caused by inflammation or tumors, and is a new strategy for the intervention of enteritis, stroke, and tumor metastasis.

Eclutatug
T9901A-389
Eclutatug (ALE C04) is a humanised antibody targeting claudin-1 (CLDN1), which can be used for the treatment of tumours and organ fibrosis indications, such as head and neck squamous cell carcinoma (HNSCC).
  • $289
In Stock
Size
QTY
Osemitamab
T815942460539-61-9
Osemitamab (TST001) is a humanised monoclonal antibody targeting claudin-18.2, composed of a dimer of the γ-1 chain and κ chain of the human-mouse chimeric TST001. It exhibits NK cell-mediated tumour killing activity and is indicated for gastric gastric-oesophageal junction adenocarcinoma, PDAC, and lung cancer.
  • $247
In Stock
Size
QTY